The growing prevalence of health related disorders such as obesity and diabetes has led to an increase in the demand for ready-to-use insulin for intra venous (IV) infusion. According to W.H.O. (World Health Organization), diabetes was ranked as the seventh leading cause of death that resulted in 1.6 million deaths in 2016. 更多
